Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H15ClN6O3 |
Molecular Weight | 374.782 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=C(N=C1)N2[C@@H](OC(=O)N3CCNCC3)C4=C(N=CC=N4)C2=O
InChI
InChIKey=CGSFZSTXVVJLIX-HNNXBMFYSA-N
InChI=1S/C16H15ClN6O3/c17-10-1-2-11(21-9-10)23-14(24)12-13(20-4-3-19-12)15(23)26-16(25)22-7-5-18-6-8-22/h1-4,9,15,18H,5-8H2/t15-/m0/s1
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2111339 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12130723 |
|||
Target ID: CHEMBL2111413 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12130723 |
|||
Target ID: GABA A receptor alpha-1/beta-2/gamma-2 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12130723 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9864389
Created by
admin on Sat Dec 16 08:14:47 GMT 2023 , Edited by admin on Sat Dec 16 08:14:47 GMT 2023
|
PRIMARY | |||
|
151776-26-0
Created by
admin on Sat Dec 16 08:14:47 GMT 2023 , Edited by admin on Sat Dec 16 08:14:47 GMT 2023
|
PRIMARY | |||
|
31WTK8F84C
Created by
admin on Sat Dec 16 08:14:47 GMT 2023 , Edited by admin on Sat Dec 16 08:14:47 GMT 2023
|
PRIMARY |
PARENT (METABOLITE)
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD